Growth HormoneResearch
Ghrelin
Also known as: GHRL · Lenomorelin
The endogenous 28-amino-acid hunger hormone from which all synthetic GHRPs are derived. Used to treat cancer cachexia and gastroparesis.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
1–5 mcg/kg
Administration
Subcutaneous or IV injection
Mechanism of Action
Natural GHS-R1a ligand that stimulates GH release, appetite, gastric motility, and energy storage through hypothalamic signaling.
Key Research Areas
growth hormonehungercachexiaendogenous
Frequently Asked Questions
What is Ghrelin?▾
The endogenous 28-amino-acid hunger hormone from which all synthetic GHRPs are derived. Used to treat cancer cachexia and gastroparesis.
How does Ghrelin work?▾
Natural GHS-R1a ligand that stimulates GH release, appetite, gastric motility, and energy storage through hypothalamic signaling.
What is the recommended dosage for Ghrelin?▾
The typical research dosage is 1–5 mcg/kg, administered via Subcutaneous or IV injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Ghrelin?▾
The half-life of Ghrelin is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Ghrelin FDA approved?▾
Ghrelin is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Ghrelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.